11-74456155-AATATATATATATAT-AATATATATATATATATATATATAT
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1
The NM_005472.5(KCNE3):c.*1087_*1096dupATATATATAT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.083 ( 688 hom., cov: 0)
Failed GnomAD Quality Control
Consequence
KCNE3
NM_005472.5 3_prime_UTR
NM_005472.5 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.296
Publications
0 publications found
Genes affected
KCNE3 (HGNC:6243): (potassium voltage-gated channel subfamily E regulatory subunit 3) Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a member of the potassium channel, voltage-gated, isk-related subfamily. This member is a type I membrane protein, and a beta subunit that assembles with a potassium channel alpha-subunit to modulate the gating kinetics and enhance stability of the multimeric complex. This gene is prominently expressed in the kidney. A missense mutation in this gene is associated with hypokalemic periodic paralysis. [provided by RefSeq, Jul 2008]
KCNE3 Gene-Disease associations (from GenCC):
- Brugada syndrome 6Inheritance: Unknown, AD Classification: LIMITED, NO_KNOWN Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Brugada syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.128 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_005472.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KCNE3 | NM_005472.5 | MANE Select | c.*1087_*1096dupATATATATAT | 3_prime_UTR | Exon 3 of 3 | NP_005463.1 | Q9Y6H6 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KCNE3 | ENST00000310128.9 | TSL:1 MANE Select | c.*1087_*1096dupATATATATAT | 3_prime_UTR | Exon 3 of 3 | ENSP00000310557.4 | Q9Y6H6 | ||
| KCNE3 | ENST00000875764.1 | c.*1087_*1096dupATATATATAT | 3_prime_UTR | Exon 4 of 4 | ENSP00000545823.1 | ||||
| KCNE3 | ENST00000929452.1 | c.*1087_*1096dupATATATATAT | 3_prime_UTR | Exon 4 of 4 | ENSP00000599511.1 |
Frequencies
GnomAD3 genomes AF: 0.0830 AC: 9349AN: 112648Hom.: 686 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
9349
AN:
112648
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0;AS_VQSRAC: 0AN: 0Hom.: 0 Cov.: 0AC XY: 0AN XY: 0
GnomAD4 exome
Data not reliable, filtered out with message: AC0;AS_VQSR
AC:
0
AN:
0
Hom.:
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome AF: 0.0830 AC: 9353AN: 112668Hom.: 688 Cov.: 0 AF XY: 0.0793 AC XY: 4211AN XY: 53102 show subpopulations
GnomAD4 genome
AF:
AC:
9353
AN:
112668
Hom.:
Cov.:
0
AF XY:
AC XY:
4211
AN XY:
53102
show subpopulations
African (AFR)
AF:
AC:
798
AN:
34382
American (AMR)
AF:
AC:
1246
AN:
10310
Ashkenazi Jewish (ASJ)
AF:
AC:
172
AN:
2826
East Asian (EAS)
AF:
AC:
442
AN:
3194
South Asian (SAS)
AF:
AC:
124
AN:
3268
European-Finnish (FIN)
AF:
AC:
306
AN:
4106
Middle Eastern (MID)
AF:
AC:
7
AN:
208
European-Non Finnish (NFE)
AF:
AC:
6098
AN:
52112
Other (OTH)
AF:
AC:
111
AN:
1492
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
283
566
848
1131
1414
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
ClinVar submissions
View on ClinVar Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
Pathogenic
VUS
Benign
Condition
-
1
-
Brugada syndrome (1)
-
1
-
not provided (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.